Daichi Shimbo1, C Barrett Bowling2, Emily B Levitan2, Luqin Deng2, John J Sim2, Lei Huang2, Kristi Reynolds2, Paul Muntner2. 1. From the Department of Medicine, Columbia University Medical Center, New York, NY (D.S.); Department of Veterans Affairs, Birmingham/Atlanta Geriatric Research, Education, and Clinical Center, Decatur, GA (C.B.B.); Emory University, Atlanta, GA (C.B.B.); Department of Epidemiology (E.B.L.), Department of Epidemiology (L.D.), Department of Epidemiology (L.H.), and Department of Epidemiology (P.M.), University of Alabama at Birmingham; Division of Nephrology and Hypertension, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA (J.J.S.); and Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA (K.R.). ds2231@cumc.columbia.edu. 2. From the Department of Medicine, Columbia University Medical Center, New York, NY (D.S.); Department of Veterans Affairs, Birmingham/Atlanta Geriatric Research, Education, and Clinical Center, Decatur, GA (C.B.B.); Emory University, Atlanta, GA (C.B.B.); Department of Epidemiology (E.B.L.), Department of Epidemiology (L.D.), Department of Epidemiology (L.H.), and Department of Epidemiology (P.M.), University of Alabama at Birmingham; Division of Nephrology and Hypertension, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA (J.J.S.); and Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA (K.R.).
Abstract
BACKGROUND: Antihypertensive medication use has been associated with an increased risk of falls in some but not all studies. Few data are available on the short-term risk of falls after antihypertensive medication initiation and intensification. METHODS AND RESULTS: We examined the association between initiating and intensifying antihypertensive medication and serious fall injuries in a case-crossover study of 90 127 Medicare beneficiaries who were ≥65 years old and had a serious fall injury between July 1, 2007, and December 31, 2012, based on emergency department and inpatient claims. Antihypertensive medication initiation was defined by a prescription fill with no fills in the previous year. Intensification was defined by the addition of a new antihypertensive class, and separately, titration by the addition of a new class or increase in dosage of a current class. Exposures were ascertained for the 15 days before the fall (case period) and six 15-day earlier periods (control periods). Overall, 272, 1508, and 3113 Medicare beneficiaries initiated, added a new class of antihypertensive medication or titrated therapy within 15 days of their serious fall injury. The odds for a serious fall injury was increased during the 15 days after antihypertensive medication initiation (odds ratio, 1.36 [95% confidence interval, 1.19-1.55]), adding a new class (odds ratio, 1.16 [95% confidence interval, 1.10-1.23]), and titration [odds ratio, 1.13 [95% confidence interval, 1.08-1.18]). These associations were attenuated beyond 15 days. CONCLUSIONS: Antihypertensive medication initiation and intensification was associated with a short-term, but not long-term, increased risk of serious fall injuries among older adults.
BACKGROUND: Antihypertensive medication use has been associated with an increased risk of falls in some but not all studies. Few data are available on the short-term risk of falls after antihypertensive medication initiation and intensification. METHODS AND RESULTS: We examined the association between initiating and intensifying antihypertensive medication and serious fall injuries in a case-crossover study of 90 127 Medicare beneficiaries who were ≥65 years old and had a serious fall injury between July 1, 2007, and December 31, 2012, based on emergency department and inpatient claims. Antihypertensive medication initiation was defined by a prescription fill with no fills in the previous year. Intensification was defined by the addition of a new antihypertensive class, and separately, titration by the addition of a new class or increase in dosage of a current class. Exposures were ascertained for the 15 days before the fall (case period) and six 15-day earlier periods (control periods). Overall, 272, 1508, and 3113 Medicare beneficiaries initiated, added a new class of antihypertensive medication or titrated therapy within 15 days of their serious fall injury. The odds for a serious fall injury was increased during the 15 days after antihypertensive medication initiation (odds ratio, 1.36 [95% confidence interval, 1.19-1.55]), adding a new class (odds ratio, 1.16 [95% confidence interval, 1.10-1.23]), and titration [odds ratio, 1.13 [95% confidence interval, 1.08-1.18]). These associations were attenuated beyond 15 days. CONCLUSIONS: Antihypertensive medication initiation and intensification was associated with a short-term, but not long-term, increased risk of serious fall injuries among older adults.
Authors: Jonathan Gribbin; Richard Hubbard; John Gladman; Chris Smith; Sarah Lewis Journal: Pharmacoepidemiol Drug Saf Date: 2011-07-11 Impact factor: 2.890
Authors: Mary E Tinetti; Ling Han; David S H Lee; Gail J McAvay; Peter Peduzzi; Cary P Gross; Bingqing Zhou; Haiqun Lin Journal: JAMA Intern Med Date: 2014-04 Impact factor: 21.873
Authors: Paul A James; Suzanne Oparil; Barry L Carter; William C Cushman; Cheryl Dennison-Himmelfarb; Joel Handler; Daniel T Lackland; Michael L LeFevre; Thomas D MacKenzie; Olugbenga Ogedegbe; Sidney C Smith; Laura P Svetkey; Sandra J Taler; Raymond R Townsend; Jackson T Wright; Andrew S Narva; Eduardo Ortiz Journal: JAMA Date: 2014-02-05 Impact factor: 56.272
Authors: Elizabeth Mostofsky; Malcolm Maclure; Jane B Sherwood; Geoffrey H Tofler; James E Muller; Murray A Mittleman Journal: Circulation Date: 2012-01-09 Impact factor: 29.690
Authors: Mark S Link; Heike Luttmann-Gibson; Joel Schwartz; Murray A Mittleman; Benjamin Wessler; Diane R Gold; Douglas W Dockery; Francine Laden Journal: J Am Coll Cardiol Date: 2013-06-13 Impact factor: 24.094
Authors: Michael A Weber; Ernesto L Schiffrin; William B White; Samuel Mann; Lars H Lindholm; John G Kenerson; John M Flack; Barry L Carter; Barry J Materson; C Venkata S Ram; Debbie L Cohen; Jean-Claude Cadet; Roger R Jean-Charles; Sandra Taler; David Kountz; Raymond Townsend; John Chalmers; Agustin J Ramirez; George L Bakris; Jiguang Wang; Aletta E Schutte; John D Bisognano; Rhian M Touyz; Dominic Sica; Stephen B Harrap Journal: J Hypertens Date: 2014-01 Impact factor: 4.844
Authors: Lesley D Gillespie; M Clare Robertson; William J Gillespie; Catherine Sherrington; Simon Gates; Lindy M Clemson; Sarah E Lamb Journal: Cochrane Database Syst Rev Date: 2012-09-12
Authors: Shia T Kent; Daichi Shimbo; Lei Huang; Keith M Diaz; Meredith L Kilgore; Suzanne Oparil; Paul Muntner Journal: PLoS One Date: 2014-08-25 Impact factor: 3.240
Authors: J C Munson; J P W Bynum; J-E Bell; C McDonough; Q Wang; T Tosteson; A N A Tosteson Journal: Osteoporos Int Date: 2018-09-19 Impact factor: 4.507
Authors: Laura C Plantinga; Raymond J Lynch; Rachel E Patzer; Stephen O Pastan; C Barrett Bowling Journal: Clin J Am Soc Nephrol Date: 2018-03-06 Impact factor: 8.237
Authors: Stephen P Juraschek; Lara M Simpson; Barry R Davis; Jennifer L Beach; Anthony Ishak; Kenneth J Mukamal Journal: Hypertension Date: 2019-09-03 Impact factor: 10.190
Authors: Stephen P Juraschek; Jiun-Ruey Hu; Jennifer L Cluett; Anthony Ishak; Carol Mita; Lewis A Lipsitz; Lawrence J Appel; Nigel S Beckett; Ruth L Coleman; William C Cushman; Barry R Davis; Greg Grandits; Rury R Holman; Edgar R Miller; Ruth Peters; Jan A Staessen; Addison A Taylor; Lutgarde Thijs; Jackson T Wright; Kenneth J Mukamal Journal: Ann Intern Med Date: 2020-09-10 Impact factor: 25.391
Authors: Samantha G Bromfield; Cedric-Anthony Ngameni; Lisandro D Colantonio; C Barrett Bowling; Daichi Shimbo; Kristi Reynolds; Monika M Safford; Maciej Banach; Peter P Toth; Paul Muntner Journal: Hypertension Date: 2017-06-26 Impact factor: 10.190
Authors: Karen L Margolis; David M Buchner; Michael J LaMonte; Yuzheng Zhang; Chongzhi Di; Eileen Rillamas-Sun; Julie Hunt; Farha Ikramuddin; Wenjun Li; Steve Marshall; Dori Rosenberg; Marcia L Stefanick; Robert Wallace; Andrea Z LaCroix Journal: J Am Geriatr Soc Date: 2019-01-07 Impact factor: 5.562
Authors: Katherine B Santosa; Yen-Ling Lai; Chad M Brummett; Jeremie D Oliver; Hsou-Mei Hu; Michael J Englesbe; Emilie M Blair; Jennifer F Waljee Journal: J Gen Intern Med Date: 2020-08-03 Impact factor: 5.128